Harvard University, Professor of Stem Cell and Regenerative Biology Mark Fishman currently serves as Professor in the Harvard Department of Stem Cell and Regenerative Biology and Chief of the Pathways Clinical Service at
the MGH for patients with complex medical disorders. He was previously Chief of Cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine. Fishman was appointed President of the newly founded Novartis Institutes for Bio Medical Research in 2002 to implement a new strategy in Novartis’ global drug discovery effort. During his tenure, NIBR discovered and brought through successful clinical trials of 90 new medicines in more than 120 indications. He is the author of over100 publications and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.